Yantai Zhenghai Biotechnology Co., Ltd.

SZSE:300653 Rapport sur les actions

Capitalisation boursière : CN¥3.7b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Yantai Zhenghai Biotechnology Croissance future

Future contrôle des critères 5/6

Yantai Zhenghai Biotechnology is forecast to grow earnings and revenue by 22.1% and 19.6% per annum respectively. EPS is expected to grow by 22.2% per annum. Return on equity is forecast to be 23.8% in 3 years.

Informations clés

22.1%

Taux de croissance des bénéfices

22.2%

Taux de croissance du BPA

Biotechs croissance des bénéfices34.3%
Taux de croissance des recettes19.6%
Rendement futur des capitaux propres23.8%
Couverture par les analystes

Low

Dernière mise à jour09 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Mar 04
Yantai Zhenghai Biotechnology Co., Ltd. (SZSE:300653) Held Back By Insufficient Growth Even After Shares Climb 26%

Prévisions de croissance des bénéfices et des revenus

SZSE:300653 - Estimations futures des analystes et données financières antérieures (CNY Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026636296N/A3011
12/31/2025547253N/A2642
12/31/2024453208N/A2242
6/30/2024387167143174N/A
3/31/2024394178135165N/A
12/31/2023414191149180N/A
9/30/2023414178135166N/A
6/30/2023426191122168N/A
3/31/2023425184128175N/A
1/1/2023433185132188N/A
9/30/2022440197139179N/A
6/30/2022431192179192N/A
3/31/2022416180190193N/A
12/31/2021400169156166N/A
9/30/2021378149109171N/A
6/30/202136014469150N/A
3/31/202135114338143N/A
12/31/202029311815118N/A
9/30/202029512335115N/A
6/30/202028211150115N/A
3/31/20202631002891N/A
12/31/201928010741103N/A
9/30/20192511004491N/A
6/30/2019243974683N/A
3/31/2019230916184N/A
12/31/2018216867177N/A
9/30/2018216887177N/A
6/30/2018204816677N/A
3/31/201819376N/A76N/A
12/31/201718362N/A65N/A
9/30/201717654N/A68N/A
6/30/201716447N/A60N/A
3/31/201715946N/A56N/A
12/31/201615145N/A49N/A
6/30/201613843N/A45N/A
3/31/201612641N/A41N/A
12/31/201512842N/A46N/A
12/31/201410534N/A31N/A
12/31/20137716N/A34N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: 300653's forecast earnings growth (22.1% per year) is above the savings rate (2.9%).

Bénéfices vs marché: 300653's earnings (22.1% per year) are forecast to grow faster than the CN market (21.9% per year).

Croissance élevée des bénéfices: 300653's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: 300653's revenue (19.6% per year) is forecast to grow faster than the CN market (13.4% per year).

Croissance élevée des revenus: 300653's revenue (19.6% per year) is forecast to grow slower than 20% per year.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: 300653's Return on Equity is forecast to be high in 3 years time (23.8%)

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y